Get my own profile
Public access
View all28 articles
6 articles
available
not available
Based on funding mandates
Co-authors
Marwin SeglerMicrosoft Research AI for ScienceVerified email at microsoft.com
Peter ErtlLeading Scientist at Ertl MolecularVerified email at peter-ertl.com
Sarah R. LangdonPhD Student, The Institute of Cancer ResearchVerified email at icr.ac.uk
Joshua MeyersProtein Engineering AI Lead, Synteny BiotechnologyVerified email at synteny.ai
Richard BaylissProfessor, University of LeedsVerified email at leeds.ac.uk
Yi MokBenevolentAIVerified email at benevolent.ai
Lewis R. VidlerComputational Medicinal Chemist, Eli Lilly and CompanyVerified email at lilly.com
Stefan KnappUniversity of FrankfurtVerified email at pharmchem.uni-frankfurt.de
Nicholas FirthVerified email at ucl.ac.uk
Richard A. LewisNovartis, BaselVerified email at novartis.com
Christos A NicolaouSenior Scientific Director, Computational Drug Discovery, Novo NordiskVerified email at novonordisk.com
Isaac WestwoodThe Institute of Cancer ResearchVerified email at icr.ac.uk
Jeremy L. JenkinsUS Head Discovery Sciences, Novartis BioMedical ResearchVerified email at novartis.com
Oleg FedorovUniversity of OxfordVerified email at cmd.ox.ac.uk
Panagis FilippakopoulosAssociate Professor, Oxford UniversityVerified email at sgc.ox.ac.uk
Fabio BroccatelliDirector at Altos LabsVerified email at altoslabs.com
George PapadatosHead of Data, Syngenta CP R&DVerified email at syngenta.com
Ruth BrenkUniversity of BergenVerified email at uib.no
Pascal FuretDirector and leading scientist at NovartisVerified email at novartis.com
Val GilletUniversity of SheffieldVerified email at sheffield.ac.uk